U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 500

1.
Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology
Yoichi Naito, Saori Mishima, Kiwamu Akagi, Ataru Igarashi, Masafumi Ikeda, Susumu Okano, Shunsuke Kato, Tadao Takano, Katsuya Tsuchihara, Keita Terashima, Hiroshi Nishihara, Hiroyki Nishiyama, Eiso Hiyama, Akira Hirasawa, Hajime Hosoi, Osamu Maeda, Yasushi Yatabe, Wataru Okamoto, Shigeru Ono, Hiroaki Kajiyama, Fumio Nagashima, Yutaka Hatanaka, Mitsuru Miyachi, Yasuhiro Kodera, Takayuki Yoshino, Hiroya Taniguchi
Int J Clin Oncol. 2020; 25(3): 403–417. Published online 2020 Jan 24. doi: 10.1007/s10147-019-01610-y
PMCID:
PMC7046581
AbstractArticlePDF–1.0M
2.
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors
Yoichi Naito, Saori Mishima, Kiwamu Akagi, Naomi Hayashi, Akira Hirasawa, Tomoro Hishiki, Ataru Igarashi, Masafumi Ikeda, Shigenori Kadowaki, Hiroaki Kajiyama, Motohiro Kato, Hirotsugu Kenmotsu, Yasuhiro Kodera, Keigo Komine, Takafumi Koyama, Osamu Maeda, Mitsuru Miyachi, Hiroshi Nishihara, Hiroyuki Nishiyama, Shouichi Ohga, Wataru Okamoto, Eiji Oki, Shigeru Ono, Masashi Sanada, Ikuo Sekine, Tadao Takano, Kayoko Tao, Keita Terashima, Katsuya Tsuchihara, Yasushi Yatabe, Takayuki Yoshino, Eishi Baba
Int J Clin Oncol. 2023; 28(7): 827–840. Published online 2023 May 22. doi: 10.1007/s10147-023-02345-7
PMCID:
PMC10310565
AbstractArticlePDF–779K
3.
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study
Vivek Subbiah, Irene Braña, Alessandra Longhi, Valentina Boni, Jean-Pierre Delord, Ahmad Awada, Pascaline Boudou-Rouquette, John Sarantopoulos, Geoffrey I. Shapiro, Anthony Elias, Ravin Ratan, Cristian Fernandez, Carmen Kahatt, Martin Cullell-Young, Mariano Siguero, Ali Zeaiter, Sant P. Chawla
Clin Cancer Res. 2022 Jul 1; 28(13): 2762–2770. Published online 2022 Apr 29. doi: 10.1158/1078-0432.CCR-22-0696
PMCID:
PMC9306456
AbstractArticlePDF–477K
4.
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib
James C. H. Yang, Marcia S. Brose, Gilberto Castro, Edward S. Kim, Ulrik N. Lassen, Serge Leyvraz, Alberto Pappo, Fernando López-Ríos, John A. Reeves, Marc Fellous, Frédérique Penault-Llorca, Erin R. Rudzinski, Ghazaleh Tabatabai, Gilles Vassal, Alexander Drilon, Jonathan Trent
BMC Cancer. 2022; 22: 625. Published online 2022 Jun 7. doi: 10.1186/s12885-022-09687-x
PMCID:
PMC9171956
AbstractArticlePDF–1013K
5.
Low IL7R Expression at Diagnosis Predicted Relapse in Adult Acute Myeloid Leukemia Patients With t(8;21)
Nan Xu, Kai Sun, Ya-Zhe Wang, Wen-Min Chen, Jun Wang, Ling-Di Li, Xu Wang, Yue Hao, Yan Chang, Yan-Rong Liu, Xiao-Jun Huang, Ya-Zhen Qin
Front Immunol. 2022; 13: 909104. Published online 2022 Jul 7. doi: 10.3389/fimmu.2022.909104
PMCID:
PMC9302488
AbstractArticlePDF–1.0M
6.
Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions
Peng Zhang, Yang Zhang, Nan Ji
Front Immunol. 2022; 13: 927132. Published online 2022 Jul 7. doi: 10.3389/fimmu.2022.927132
PMCID:
PMC9300859
AbstractArticlePDF–4.0M
7.
Primary uterine broad ligament ependymoma with CHEK2p.H371Y germline mutation: A CARE‐compliant case report uterine broad ligament ependymoma
Jiaxin Yin, Min Yao, Hongdi Lu, Xiaofeng Cong, Pengfei Cui, Ziling Liu
J Obstet Gynaecol Res. 2022 Jan; 48(1): 266–270. Published online 2021 Oct 30. doi: 10.1111/jog.15065
PMCID:
PMC9298396
AbstractArticlePDF–1.3M
8.
LINC00313 regulates the metastasis of testicular germ cell tumors through epithelial-mesenchyme transition and immune pathways
Zhizhong Liu, Bairong Fang, Jian Cao, Qianyin Zhou, Fang Zhu, Liqing Fan, Lei Xue, Chuan Huang, Hao Bo
Bioengineered. 2022; 13(5): 12141–12155. Published online 2022 May 16. doi: 10.1080/21655979.2022.2073128
PMCID:
PMC9275957
AbstractArticlePDF–29M
9.
Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease
Eric Jonasch, Frede Donskov, Othon Iliopoulos, W. Kimryn Rathmell, Vivek K. Narayan, Benjamin L. Maughan, Stephane Oudard, Tobias Else, Jodi K. Maranchie, Sarah J. Welsh, Sanjay Thamake, Eric K. Park, Rodolfo F. Perini, W. Marston Linehan, Ramaprasad Srinivasan
N Engl J Med. Author manuscript; available in PMC 2022 Jul 12.
Published in final edited form as: N Engl J Med. 2021 Nov 25; 385(22): 2036–2046. doi: 10.1056/NEJMoa2103425
PMCID:
PMC9275515
AbstractArticlePDF–787K
10.
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial
Olive S. Eckstein, Carl E. Allen, P. Mickey Williams, Sinchita Roy-Chowdhuri, David R. Patton, Brent Coffey, Joel M. Reid, Jin Piao, Lauren Saguilig, Todd A. Alonzo, Stacey L. Berg, Nilsa C. Ramirez, Alok Jaju, Joyce Mhlanga, Elizabeth Fox, Douglas S. Hawkins, Margaret M. Mooney, Naoko Takebe, James V. Tricoli, Katherine A. Janeway, Nita L. Seibel, D. Williams Parsons
J Clin Oncol. 2022 Jul 10; 40(20): 2235–2245. Published online 2022 Apr 1. doi: 10.1200/JCO.21.02840
PMCID:
PMC9273373
AbstractArticlePDF–663K
11.
SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling
Lu Liu, Lin Yang, Xiaojun Liu, Menghan Liu, Jing Liu, Xuefeng Feng, Ziyuan Nie, Jianmin Luo
J Transl Med. 2022; 20: 304. Published online 2022 Jul 6. doi: 10.1186/s12967-022-03500-w
PMCID:
PMC9258142
AbstractArticlePDF–6.2M
12.
Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C Mutation
Judy Wang, Patricia Martin-Romano, Philippe Cassier, Melissa Johnson, Eric Haura, Laurie Lenox, Yue Guo, Nibedita Bandyopadhyay, Michael Russell, Elizabeth Shearin, Josh Lauring, Laetitia Dahan
Oncologist. 2022 Jul; 27(7): 536–e553. Published online 2022 Mar 24. doi: 10.1093/oncolo/oyab080
PMCID:
PMC9255981
AbstractArticlePDF–393K
13.
Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878)
Jonathan W Riess, Karen L Reckamp, Paul Frankel, Jeffrey Longmate, Karen A Kelly, David R Gandara, Caroline M Weipert, Victoria M Raymond, Harold N Keer, Philip C Mack, Edward M Newman, Primo N Lara, Jr.
Clin Lung Cancer. Author manuscript; available in PMC 2022 Jun 28.
Published in final edited form as: Clin Lung Cancer. 2021 Nov; 22(6): 541–548. Published online 2021 May 15. doi: 10.1016/j.cllc.2021.05.001
PMCID:
PMC9239707
AbstractArticlePDF–694K
14.
Timing of NTRK Gene Fusion Testing and Treatment Modifications Following TRK Fusion Status Among US Oncologists Treating TRK Fusion Cancer
Andrew J. Klink, Abhishek Kavati, Awa T. Gassama, Tom Kozlek, Ajeet Gajra, Ruth Antoine
Target Oncol. 2022; 17(3): 321–328. Published online 2022 Jun 18. doi: 10.1007/s11523-022-00887-w
PMCID:
PMC9217884
AbstractArticlePDF–720K
15.
Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels
Biagio Ricciuti, Xinan Wang, Joao V. Alessi, Hira Rizvi, Navin R. Mahadevan, Yvonne Y. Li, Andrew Polio, James Lindsay, Renato Umeton, Rileen Sinha, Natalie I. Vokes, Gonzalo Recondo, Giuseppe Lamberti, Marissa Lawrence, Victor R. Vaz, Giulia C. Leonardi, Andrew J. Plodkowski, Hersh Gupta, Andrew D. Cherniack, Michael Y. Tolstorukov, Bijaya Sharma, Kristen D. Felt, Justin F. Gainor, Arvind Ravi, Gad Getz, Kurt A. Schalper, Brian Henick, Patrick Forde, Valsamo Anagnostou, Pasi A. Jänne, Eliezer M. Van Allen, Mizuki Nishino, Lynette M. Sholl, David C. Christiani, Xihong Lin, Scott J. Rodig, Matthew D. Hellmann, Mark M. Awad
JAMA Oncol. 2022 Aug; 8(8): 1160–1168. Published online 2022 Jun 16. doi: 10.1001/jamaoncol.2022.1981
Correction in:
JAMA Oncol. 2022 Nov; 8(11): 1702.
PMCID:
PMC9204620
AbstractArticle
16.
The immune landscape of solid pediatric tumors
Shimaa Sherif, Jessica Roelands, William Mifsud, Eiman I. Ahmed, Christophe M. Raynaud, Darawan Rinchai, Abbirami Sathappan, Ata Maaz, Ayman Saleh, Erdener Ozer, Khalid A. Fakhro, Borbala Mifsud, Vésteinn Thorsson, Davide Bedognetti, Wouter R. L. Hendrickx
J Exp Clin Cancer Res. 2022; 41: 199. Published online 2022 Jun 11. doi: 10.1186/s13046-022-02397-z
PMCID:
PMC9188257
AbstractArticlePDF–6.0M
17.
Peripancreatic paraganglioma: Lesson from a round table
Federica Petrelli, Geri Fratini, Andrea Sbrozzi-Vanni, Andrea Giusti, Raffele Manta, Claudio Vignali, Gabriella Nesi, Andrea Amorosi, Andrea Cavazzana, Marco Arganini, Maria Raffaella Ambrosio
World J Gastroenterol. 2022 Jun 7; 28(21): 2396–2402. Published online 2022 Jun 7. doi: 10.3748/wjg.v28.i21.2396
PMCID:
PMC9185219
AbstractArticlePDF–12M
18.
A framework for fibrolamellar carcinoma research and clinical trials
Timothy A. Dinh, Alan F. Utria, Kevin C. Barry, Rosanna Ma, Ghassan K. Abou-Alfa, John D. Gordan, Elizabeth M. Jaffee, John D. Scott, Jessica Zucman-Rossi, Allison F. O’Neill, Mark E. Furth, Praveen Sethupathy
Nat Rev Gastroenterol Hepatol. Author manuscript; available in PMC 2023 May 1.
Published in final edited form as: Nat Rev Gastroenterol Hepatol. 2022 May; 19(5): 328–342. Published online 2022 Feb 21. doi: 10.1038/s41575-022-00580-3
PMCID:
PMC9516439
AbstractArticlePDF–899K
19.
MCL1 as putative target in pancreatoblastoma
Timm M. Reissig, Sebastian Uhrig, Philipp J. Jost, Claudio Luchini, Caterina Vicentini, Sven-Thorsten Liffers, Michael Allgäuer, Volkan Adsay, Aldo Scarpa, Rita Teresa Lawlor, Stefan Fröhling, Albrecht Stenzinger, Günter Klöppel, Hans-Ulrich Schildhaus, Jens T. Siveke
Virchows Arch. 2022; 481(2): 265–272. Published online 2022 Jun 7. doi: 10.1007/s00428-022-03349-w
PMCID:
PMC9343273
AbstractArticlePDF–1.2M
20.
Potential of chimeric antigen receptor (CAR)‐redirected immune cells in breast cancer therapies: Recent advances
Marzieh Nikoo, Mohammad Rudiansyah, Dmitry Olegovich Bokov, Nurlan T. Jainakbaev, Wanich Suksatan, Mohammad Javed Ansari, Lakshmi Thangavelu, Supat Chupradit, Amir Zamani, Ali Adili, Navid Shomali, Morteza Akbari
J Cell Mol Med. 2022 Aug; 26(15): 4137–4156. Published online 2022 Jun 28. doi: 10.1111/jcmm.17465
PMCID:
PMC9344815
AbstractArticlePDF–5.9M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center